BioSpace News Archive

Pharm Country

Clinical Ink Implements COVID-19 Therapy Trial in Three Weeks Facilitates Earlier Results for Potential Cytokine Storm Treatment

Clinical Ink, a global clinical trial technology company, has helped expedite the study of a treatment for cytokine storm, the immunological reaction associated with severe cases of COVID-19.

June 3, 2020
·
1 min read
Appili Therapeutics Announces Overnight Marketed Equity Offering - June 03, 2020

Appili Therapeutics Inc., a biopharmaceutical company focused on anti-infective drug development, has announced that it will undertake an overnight marketed public offering of units, comprised of Class A common shares and Class A common share purchase warrants.

June 3, 2020
·
5 min read
Deals

AcelRx Pharmaceuticals Announces It Will Not Further Revise Its Offer to Acquire Tetraphase

AcelRx Pharmaceuticals, Inc. announced that it does not intend to revise further its offer under the terms of its previously announced agreement to acquire Tetraphase Pharmaceuticals, Inc., and it expects the agreement to be terminated by Tetraphase.

June 3, 2020
·
4 min read
Deals

OraSure Technologies, Inc. Announces Exercise of Option to Purchase Additional Shares of Common Stock - June 04, 2020

OraSure Technologies, Inc. announced the full exercise by the underwriters of their option to purchase an additional 1,200,000 shares of its common stock in connection with the Company’s previously announced offering that priced on June 2, 2020.

June 3, 2020
·
8 min read